Long‐Term Outcomes of Gonadotropin‐Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal‐Weight Girls
Clinical Endocrinology · 30.07.2026
DOI: 10.1111/cen.70195 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Endocrinology, online erschienen am 30.07.2026. Verfasst von Natee Sakornyutthadej und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand. Hauptthemen laut MEDLINE: Puberty, Precocious, Gonadotropin-Releasing Hormone, Obesity. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
To determine final height (FH), body mass index (BMI) changes, and age at menarche in obese girls with idiopathic central precocious puberty (CPP) treated with gonadotropin‐releasing hormone analogue (GnRHa), compared with their normal‐weight counterparts. Design, Patients and Measurements Height outcomes, FH, BMI changes and age at menarche of girls with idiopathic CPP treated with GnRHa who had reached FH were reviewed. Comparisons were performed between the overweight/obese and normal‐weight groups.
Results
A total of 726 patients were enroled (269 overweight/obese and 457 normal‐weight). At diagnosis, overweight/obese girls were taller (median (interquartile range) height standard deviation score (SDS): 1.53 (0.69, 2.12) versus 0.80 (0.28, 1.40), p < 0.001), and had greater degree of bone age advancement (2.5 (1.8, 3.2) vs. 2.0 (1.1, 2.7) years, p < 0.001). The overweight/obese group had greater height gain (FH—initial predicted adult height) following GnRHa treatment (8.0 (4.4, 11.5) vs. 6.8 (3.6, 10.7) cm, p = 0.010). BMI SDSs at FH were less than those at diagnosis in both groups (overweight/obese: 1.26 (0.52, 2.07) vs. 1.70 (1.23, 2.51), and normal‐weight: −0.23 (−0.79, 0.47) versus 0.26 (−0.35, 0.67), p < 0.001). Notably, 109 overweight/obese girls had normalised BMI SDS at FH. The interval from GnRHa discontinuation to menarche was comparable between the two groups (14.4 (8.4, 19.2) vs. 14.4 (9.6, 19.2) months, p = 0.961).
Conclusions
GnRHa therapy had a beneficial effect on height gain in both CPP girls with overweight/obesity and normal weight. BMI SDSs at FH were less than those at diagnosis in both groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
- Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Natee Sakornyutthadej, Pat Mahachoklertwattana, Sarunyu Pongratanakul, Orapan Upakankul, Preamrudee Poomthavorn
Zitieren
APA
Sakornyutthadej, N., Pruksasri, J., Mahachoklertwattana, P., Pongratanakul, S., Upakankul, O., & Poomthavorn, P. (2026). Long‐Term Outcomes of Gonadotropin‐Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal‐Weight Girls. Clinical Endocrinology. https://doi.org/10.1111/cen.70195
Vancouver
Sakornyutthadej N, Pruksasri J, Mahachoklertwattana P, Pongratanakul S, Upakankul O, Poomthavorn P. Long‐Term Outcomes of Gonadotropin‐Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal‐Weight Girls. Clinical Endocrinology. 2026. doi:10.1111/cen.70195
BibTeX
@article{Sakornyutthadej2026,
author = {Sakornyutthadej, Natee and Pruksasri, Jirawat and Mahachoklertwattana, Pat and Pongratanakul, Sarunyu and Upakankul, Orapan and Poomthavorn, Preamrudee},
title = {Long‐Term Outcomes of Gonadotropin‐Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal‐Weight Girls},
journal = {Clinical Endocrinology},
year = {2026},
doi = {10.1111/cen.70195}
}
EUVIMED